BRIEF published on 10/20/2026 at 22:20, 2 days 5 hours ago Voting Rights and Shares Capital of NANOBIOTIX Voting Rights Euronext Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 10/20/2026 at 22:20, 2 days 5 hours ago Informations sur le Capital de Nanobiotix Droits De Vote Euronext Actions Nasdaq NANOBIOTIX
BRIEF published on 10/20/2026 at 22:20, 2 days 5 hours ago Droits de vote et capital social de NANOBIOTIX Euronext Capital Social Nasdaq Droit De Vote NANOBIOTIX
BRIEF published on 10/20/2026 at 22:20, 2 days 5 hours ago Information on Nanobiotix Capital Voting Rights Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE published on 10/20/2026 at 22:15, 2 days 5 hours ago Voting Rights and Shares Capital of the Company Nanobiotix reports voting rights and shares capital. Company listed on Euronext Paris and Nasdaq. Focus on disruptive therapeutic approaches. Headquarters in Paris, France Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE published on 10/20/2026 at 22:15, 2 days 5 hours ago Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Publication mensuelle des droits de vote et actions de Nanobiotix. Information sur les chiffres clés du capital social. Présentation de l'entreprise et de ses activités Capital Social Biotechnologie Traitements NANOBIOTIX Physique
BRIEF published on 10/01/2026 at 22:20, 21 days 5 hours ago NANOBIOTIX nomme Arnd Christ au poste de directeur financier Biotechnologie Nomination Directeur Financier NANOBIOTIX Arnd Christ
BRIEF published on 10/01/2026 at 22:20, 21 days 5 hours ago NANOBIOTIX appoints Arnd Christ as Chief Financial Officer Chief Financial Officer Biotechnology Appointment NANOBIOTIX Arnd Christ
BRIEF published on 10/01/2026 at 22:20, 21 days 5 hours ago NANOBIOTIX nomme Arnd Christ au poste de directeur financier Biotechnologie Nomination Du Directeur Financier Leadership Financier NANOBIOTIX Arnd Christ
BRIEF published on 10/01/2026 at 22:20, 21 days 5 hours ago NANOBIOTIX Appoints Arnd Christ as CFO Biotechnology CFO Appointment Financial Leadership NANOBIOTIX Arnd Christ
Published on 10/23/2026 at 02:20, 1 hour 27 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 4 hours 17 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 5 hours 17 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 11 hours 47 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 13 hours 17 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 01:55, 1 hour 51 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 5 hours 36 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 7 hours 46 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 8 hours 2 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 9 hours 1 minute ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
